维普中文期刊产品整合服务
18篇 您的检索式:作者名="Pang TC"
    题名 作者 年代 出处 被引量
1Space-occupying benign lesions in spleen:experiences in a single institute显示文摘Pang WB Zhang TC Chen YJ et ai 2009Pediatr 8urg Int2009,25,1:1
2Specific IgG and lgA of common foods in Chinese children with eczema: friend or foe 显示文摘Hon KL Pooh TC Pang NH 2014J Derma- tolog Treat2014,25,6:1
3Accuracy of ambulatory blood pressure monitors in routine clinical practice显示文摘Pang TC Brown MA 2006Am J Hypertens2006,19,8:1
4Stress-induced intracranial mast cell degranulation: acorticotropin-releasing hormone-mediated effect显示文摘Theoharides TC Spanos C Pang X 1995Endocrinology1995,136,12:1
5Analysis of actual health- care costs of early versus interval cholecystectomy in acute cho- leeystitis 显示文摘Tan CH Pang TC Woon WW 2015J Hepatobiliary Pancreat Sci2015,22,3:1
6Complications follow- ing liver resection for colorectal metastases do not impact on longterm outcome显示文摘Pang TC Spiro C Ramacciotti T 2015HPB (Oxford)2015,17,2:1
7Cell biology of CaZ+-triggered exocytosis 显示文摘Pang ZP Sudhof TC 2010Curr Opin Cell Biol2010,22,4:1
8Improving outcomes in adrenoeortical cancer: an australian perspective显示文摘IP JC PANG TC GLOVER AR 2014Ann Surg Oneol2014,,:1
9Proteomic analysis reveals platelet factor 4 and beta-thrornboglobulin as prognostic markers in severe acute respiratory syndrome显示文摘Poon TC Pang RT Chan KC 2012Electrophoresis2012,33,12:1
10Integrative genomic and functional analy-ses reveal neuronal subtype differentiation bias in human em-bryonic stem cell lines 显示文摘Wu H Xu J Pang ZP GeW Kim KJ Blanchi B ChenC SiadKof TC Sun YE 2007PNAS2007,104,13:1
11CortieotroPin - Releasing hormone induces skin mast cell degranul ationand Increased vascular Permeability, a Possible explanation fofits Proinfia atory effeets 显示文摘Theoharides TC Singh LK Boucher W Pang X Letoumeau E 1998Endocrinology1998,139,1:1
12Stress-induced intracranial mast cell degranulation:A corticotropinreleasing hormone-mediated effect显示文摘Theoharides TC Spanos C Pang X 1995Endocrinology1995,136,12:1
13Age-dependent 6kb deletion in human liver mitochondrial DNA 显示文摘Yen TC Pang CY Hsieh RH 1992Biochem Int1992,26,3:1
14Serum proteomic fin- gerprints of adult patients with severe acute respiratory syndrome 显示文摘PANG RT POON TC CHAN KC 2006Clin Chem2006,52,3:1
15A method of mitogen - aetivited protein kinase, activity assay显示文摘Li TC(李田昌) Pang YZ(庞永正) Su JY(苏静怡) 1999Bas Med Sci Clin1999,16,2:1
16Induction of phosphorylated-Sta3 following focal cerebral ischemia in mice显示文摘Wen TC Pang H Hata R 2001Neurosci Lett2001,303,3:1
17Genetic polymorphism ofcytochrome P450 2C19 in healthy malaysian subjects 显示文摘Pang YS Wong LP Lee TC 2004Br JClin Pharmacol2004,58,3:1
18Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies显示文摘Objective:Chemotherapy-induced nausea and vomiting(CINV)are common with doxorubicin-cyclophosphamide(AC)chemotherapy.Recommended antiemetic regimens incorporate neurokinin-1 receptor antagonist(NK1 RA),5-hydroxytryptamine type-3 receptor antagonist(5 HT3 RA),corticosteroid,and dopamine antagonists.This post-hoc analysis compared results of 3 prospective antiemetic studies conducted among Chinese breast cancer patients who received(neo)adjuvant AC,in order to identify optimal antiemetic prophylaxis.Methods:A total of 304 patients were included:Group 1,ondansetron/dexamethasone(D1);Group 2,aprepitant/ondansetron/dexamethasone(D1);Group 3,aprepitant/ondansetron/dexamethasone(D1–3);Group 4,aprepitant/ondansetron/dexamethasone(D1–3)/olanzapine;and Group 5,netupitant/palonosetron/dexamethasone(D1–3).Antiemetic efficacies of Groups 3,4,and 5 during cycle 1 of AC were individually compared with Group 1.In addition,emesis outcomes of patients in Groups 3 and 5,and those of Groups 2 and 3,were compared.Results:When comparing efficacies of a historical doublet(5 HT3 RA/dexamethasone)with triplet antiemetic regimens(NK1 RA/5 HT3 RA/dexamethasone)with/without olanzapine,complete response(CR)percentages and quality of life(QOL)in overall phase of cycle 1 AC were compared between Group 1 and the other groups:Group 1 vs.3,41.9%vs.38.3%(P=0.6849);Group 1 vs.4,41.9%vs.65.0%(P=0.0107);and Group 1 vs.5,41.9%vs.60.0%(P=0.0460).Groups 4 and 5 achieved a better QOL.When comparing netupitant-based(Group 3)with aprepitant-based(Group 5)triplet antiemetics,CR percentages were 38.3%vs.60.0%,respectively(P=0.0176);Group 5 achieved a better QOL.When comparing 1 day(Group 2)vs.3 day(Group 3)dexamethasone,CR percentages were 46.8%and 38.3%,respectively(P=0.3459);Group 3 had a worse QOL.Conclusions:Aprepitant-containing triplets were non-superior to doublet antiemetics.Netupitant-containing triplets and adding olanzapine to aprepitant-containing triplets were superior to doublets.Netupitant/palonosetron/dexamethasone was superior to aprepitant/ondansetron/dexamethasone.Protracted administration of dexamethasone provided limited additional benefit.Winnie Yeo Leung Li Thomas KH Lau Kwai T Lai Vicky,TC Chan Kwan H Wong Christopher CH Yip Elizabeth Pang Maggie Cheung Vivian Chan Carol CH Kwok Joyce JS Suen Frankie KF Mo 2021Cancer Biology & Medicine2021,18,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费